Matches in SemOpenAlex for { <https://semopenalex.org/work/W2764335093> ?p ?o ?g. }
- W2764335093 endingPage "161" @default.
- W2764335093 startingPage "155" @default.
- W2764335093 abstract "Over the past few years, direct oral anticoagulants (DOACs) have been gradually replacing warfarin. Inappropriate prescribing of DOACs in real-life practice settings can affect their perceived safety and efficacy, especially with the lack of a surrogate marker for guidance.To describe the appropriateness of DOACs prescribing, compare dabigatran to rivaroxaban in terms of inappropriate prescribing, and determine other factors associated with inappropriate DOACs use.In this cross-sectional retrospective study, 5-year DOAC prescriptions data were extracted. Appropriateness was evaluated based on approved dosing and indications in Canada and the United States. Descriptive and inferential statistics were performed using SPSS.From 2011 to 2015, there were 1049 DOACs prescriptions, among which 572 (54.5%) were for dabigatran and 477(45.5%) were for rivaroxaban. The DOACs were prescribed for inappropriate indication in 35 (3.3%) patients, while inappropriate dosing was found in 352 (33.6%) prescriptions. There were significantly more inappropriate dabigatran prescriptions compared to rivaroxaban both in terms of indication (4.7% vs 1.7%, P = .004) and dosing (50.9% vs 12.8%, P < .001). Logistic regression analysis confirmed that dabigatran prescribing was the only factor associated with inappropriate indications (odds ratio [OR] = 2.9, 95% confidence interval [CI]: 1.3-6.5). Factors associated with inappropriate dosing included dabigatran prescriptions (OR = 7.6, 95% CI: 5.5-10.5) and poor renal function (OR = 14.6, 95% CI: 3.6-58.4).Direct oral anticoagulants have been gradually replacing warfarin in Qatar; however, they are not always prescribed appropriately especially in patients on dabigatran and those with renal impairment. Educating health-care practitioners is necessary. Future studies comparing the clinical safety and effectiveness of the DOACs especially when used at an inappropriate dose are also warranted." @default.
- W2764335093 created "2017-10-20" @default.
- W2764335093 creator A5033004768 @default.
- W2764335093 creator A5039045493 @default.
- W2764335093 creator A5070620670 @default.
- W2764335093 date "2017-10-04" @default.
- W2764335093 modified "2023-09-26" @default.
- W2764335093 title "Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience" @default.
- W2764335093 cites W1532234313 @default.
- W2764335093 cites W1575823155 @default.
- W2764335093 cites W1736100602 @default.
- W2764335093 cites W1797564483 @default.
- W2764335093 cites W2000438765 @default.
- W2764335093 cites W2037466098 @default.
- W2764335093 cites W2042345206 @default.
- W2764335093 cites W2042608661 @default.
- W2764335093 cites W2051910688 @default.
- W2764335093 cites W2093049209 @default.
- W2764335093 cites W2095647706 @default.
- W2764335093 cites W2097854437 @default.
- W2764335093 cites W2106828417 @default.
- W2764335093 cites W2114701438 @default.
- W2764335093 cites W2115787552 @default.
- W2764335093 cites W2118092611 @default.
- W2764335093 cites W2127100296 @default.
- W2764335093 cites W2130199362 @default.
- W2764335093 cites W2136489990 @default.
- W2764335093 cites W2155428834 @default.
- W2764335093 cites W2225937646 @default.
- W2764335093 cites W2238101562 @default.
- W2764335093 cites W2346592320 @default.
- W2764335093 cites W2528056777 @default.
- W2764335093 cites W2532803653 @default.
- W2764335093 cites W2582505536 @default.
- W2764335093 cites W3030533492 @default.
- W2764335093 cites W4205645630 @default.
- W2764335093 cites W826970266 @default.
- W2764335093 doi "https://doi.org/10.1177/1074248417731536" @default.
- W2764335093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28978236" @default.
- W2764335093 hasPublicationYear "2017" @default.
- W2764335093 type Work @default.
- W2764335093 sameAs 2764335093 @default.
- W2764335093 citedByCount "8" @default.
- W2764335093 countsByYear W27643350932018 @default.
- W2764335093 countsByYear W27643350932019 @default.
- W2764335093 countsByYear W27643350932020 @default.
- W2764335093 crossrefType "journal-article" @default.
- W2764335093 hasAuthorship W2764335093A5033004768 @default.
- W2764335093 hasAuthorship W2764335093A5039045493 @default.
- W2764335093 hasAuthorship W2764335093A5070620670 @default.
- W2764335093 hasConcept C126322002 @default.
- W2764335093 hasConcept C151956035 @default.
- W2764335093 hasConcept C156957248 @default.
- W2764335093 hasConcept C167135981 @default.
- W2764335093 hasConcept C177713679 @default.
- W2764335093 hasConcept C194828623 @default.
- W2764335093 hasConcept C2426938 @default.
- W2764335093 hasConcept C2776301958 @default.
- W2764335093 hasConcept C2777288759 @default.
- W2764335093 hasConcept C2778661090 @default.
- W2764335093 hasConcept C2778810321 @default.
- W2764335093 hasConcept C2779161974 @default.
- W2764335093 hasConcept C2780638905 @default.
- W2764335093 hasConcept C44249647 @default.
- W2764335093 hasConcept C71924100 @default.
- W2764335093 hasConcept C98274493 @default.
- W2764335093 hasConceptScore W2764335093C126322002 @default.
- W2764335093 hasConceptScore W2764335093C151956035 @default.
- W2764335093 hasConceptScore W2764335093C156957248 @default.
- W2764335093 hasConceptScore W2764335093C167135981 @default.
- W2764335093 hasConceptScore W2764335093C177713679 @default.
- W2764335093 hasConceptScore W2764335093C194828623 @default.
- W2764335093 hasConceptScore W2764335093C2426938 @default.
- W2764335093 hasConceptScore W2764335093C2776301958 @default.
- W2764335093 hasConceptScore W2764335093C2777288759 @default.
- W2764335093 hasConceptScore W2764335093C2778661090 @default.
- W2764335093 hasConceptScore W2764335093C2778810321 @default.
- W2764335093 hasConceptScore W2764335093C2779161974 @default.
- W2764335093 hasConceptScore W2764335093C2780638905 @default.
- W2764335093 hasConceptScore W2764335093C44249647 @default.
- W2764335093 hasConceptScore W2764335093C71924100 @default.
- W2764335093 hasConceptScore W2764335093C98274493 @default.
- W2764335093 hasFunder F4320322472 @default.
- W2764335093 hasIssue "2" @default.
- W2764335093 hasLocation W27643350931 @default.
- W2764335093 hasLocation W27643350932 @default.
- W2764335093 hasOpenAccess W2764335093 @default.
- W2764335093 hasPrimaryLocation W27643350931 @default.
- W2764335093 hasRelatedWork W1980640915 @default.
- W2764335093 hasRelatedWork W2005097817 @default.
- W2764335093 hasRelatedWork W2049310472 @default.
- W2764335093 hasRelatedWork W2074627993 @default.
- W2764335093 hasRelatedWork W2134272053 @default.
- W2764335093 hasRelatedWork W2321904733 @default.
- W2764335093 hasRelatedWork W2787309434 @default.
- W2764335093 hasRelatedWork W2789710191 @default.
- W2764335093 hasRelatedWork W4213075745 @default.
- W2764335093 hasRelatedWork W1570353559 @default.